Global Medtech M&A Deals Hit $1.85 Billion in August

By MedTech Intelligence Staff
October 16, 2019


• Categories: 03-Manufacturing Execution, 05-Quality/Regulatory, Business Analysis, Market Access

The total value of global medtech M&A deals for August hit $1.85 billion, according to GlobalData. Deals in North America were worth about $1.7 billion, with the United States accounting for 13 transactions. By the end of August the total value of deals for 2019 was $30.29 billion. This number was 73.7% higher year over year. The top deals of the month included:

1. Siemens Healthineers acquiring Corindus Vascular Robotics for $1.1 billion
2. AtriCure’s purchase of SentreHEART for $300 million
3. Hil-Rom Holdings acquisition of Breathe Technologies for $130 million

There are a number of factors that a company must consider when embarking on the mergers and acquisitions process, especially surrounding due diligence. Learn more about the critical issues unique to medical device companies during the MedTech M&A Regulatory & Quality Due Diligence virtual conference on October 23–24, 2019. Areas that will be covered include:

• Unique medtech M&A challenges
• Quality due diligence
• Regulatory due diligence
• Clinical / medical due diligence
• Effective presentation of quality and regulatory findings to senior management
• Discussions with regulatory around M&A
• Budgeting and planning for post-acquisition activities
• Integration, harmonization, and remediation
• Common issues and hidden deal-breaking problems
• Case studies

Attendees can also earn CEU credits for attending the conference. MTI conference CEUs can be applied to a regulatory affairs certification.